Cargando…
Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model
Oncolytic adenoviruses (OAds) are alternative immune therapeutic strategies for tumors. However, liver uptake and antibody neutralization are two major barriers for systemic delivery during the treatment of tumor metastasis. Mesenchymal stem cells (MSCs) have emerged as potential vehicles to improve...
Autores principales: | Zhang, Yuning, Liu, Chao, Wang, Tao, Kong, Fanxuan, Zhang, Huan, Yi, Jing, Dong, Xiwen, Duan, Han, Tao, Ning, Yang, Yuefeng, Wang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850566/ https://www.ncbi.nlm.nih.gov/pubmed/35229027 http://dx.doi.org/10.1016/j.omto.2022.01.007 |
Ejemplares similares
-
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer
por: Xu, Weidong, et al.
Publicado: (2014) -
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
por: Zhang, Chen, et al.
Publicado: (2021) -
Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinoma
por: Yuan, Xiangfei, et al.
Publicado: (2023) -
A novel oncolytic adenovirus based on simian adenovirus serotype 24
por: Cheng, Tao, et al.
Publicado: (2017) -
Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model
por: Zhang, Huan, et al.
Publicado: (2021)